Phio Pharmaceuticals Corp (PHIO) Social Stream

Phio Pharmaceuticals Corp (PHIO): $1.50

0.03 (+2.04%)

POWR Rating

Component Grades








Add PHIO to Watchlist
Sign Up

Industry: Biotech




#183 of 378

in industry


The tables below show price targets and recommendations from analysts covering PHIO PHARMACEUTICALS CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-08-16 1 $6 $6 $6 $1.36 341.18%

Price Target Last Issued August 16, 2023

The Trend in the Analyst Price Target

Over the past 26 months, PHIO's average price target has gone down $0.

Over the past 39 weeks, PHIO's average upside potential has been 953.28%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-14 1 6 6 6 0.493 1117.04%
2022-12-22 1 6 6 6 0.359 1571.31%
2023-08-16 1 6 6 6 2.210 171.49%

PHIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations

PHIO's average broker recommendation rating improved by 0 over the prior 21 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PHIO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, PHIO PHARMACEUTICALS CORP's number of analysts covering the stock is higher than nearly none of them.
  • PHIO has a lower variance in analysts' estimates than just about 100% of all US stocks.
  • PHIO PHARMACEUTICALS CORP's average analyst price target is greater than 9.17% of Healthcare stocks.
  • PHIO has a higher upside potential (average analyst target price relative to current price) than 70.47% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PHIO PHARMACEUTICALS CORP are ORGS, EVOK, and NBY.

Is PHIO a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!